Generation of three iPSC lines from dilated cardiomyopathy patients carrying a pathogenic LMNA variant

Area of Science:

• Cardiovascular Biology
• Stem Cell Biology
• Genetics

Background:

• Dilated cardiomyopathy (DCM) is a severe heart condition often caused by genetic factors.
• Mutations in the LMNA gene are a known cause of inherited DCM, leading to heart enlargement and dysfunction.
• Understanding the precise mechanisms of LMNA-related DCM is crucial for developing effective treatments.

Purpose of the Study:

• To generate and characterize human induced pluripotent stem cell (iPSC) lines from patients with LMNA-related DCM.
• To establish a reliable in vitro model for studying the cellular and molecular basis of this specific form of cardiomyopathy.
• To provide a tool for future drug screening and therapeutic development for LMNA mutations.

Main Methods:

• Isolation of peripheral blood mononuclear cells (PBMCs) from three DCM patients with a specific heterozygous LMNA mutation (c.1129C>T).
• Reprogramming of PBMCs into induced pluripotent stem cells (iPSCs).
• Characterization of iPSC lines for pluripotency markers, morphology, karyotype stability, and differentiation potential into three germ layers.

Main Results:

• Successfully generated three distinct human iPSC lines from DCM patients.
• Confirmed that all iPSC lines exhibited typical pluripotent stem cell characteristics, including morphology and marker expression.
• Verified normal karyotypes and the ability of iPSCs to differentiate into ectoderm, mesoderm, and endoderm.
• Demonstrated the presence of the specific heterozygous LMNA mutation in all generated iPSC lines.

Conclusions:

• The generated iPSC lines carrying the LMNA mutation are a faithful cellular model of DCM.
• These iPSC lines provide a powerful platform for investigating the pathological mechanisms underlying LMNA-related dilated cardiomyopathy in vitro.
• This resource will facilitate research into novel therapeutic strategies for patients with genetic cardiomyopathies.